期刊名称 《临床用药研究》
英文刊名 Clinical Pharmacotherapy Research
国际刊号 ISSN 3105-6741 (印刷版) ISSN 3105-675X (网络版)
CODEN：LYYAA3 国际标准连续出版物标识符·全球唯一标识符，由美国化学文摘社 CAS 分配
出版模式 金色开放获取 (Gold OA)，遵循 CC BY 4.0 协议，全文永久免费获取
出版机构 Macau Sino-Foreign Medical Publishing Limited
出版频率 双月刊
出版语言 中文、英文
投稿语言 中文 (须同时提交英文标题、摘要、关键词、作者姓名及单位信息)
发行支持 国图集团 (CIBTC)
进口备案刊号 G015Z125
本刊已获全球多家权威学术数据库收录，致力于推动高质量研究的全球传播，与全球学者携手，共建开放、协作、前瞻的国际学术共同体。
一、期刊定位
《临床用药研究》是一本立足国际化视野、聚焦医学前沿研究与创新治疗技术的学术期刊。本刊致力于促进基础医学研究与临床实践的有效融合，重点关注创新药物研发、精准医疗、生物技术等前沿方向。我们特别倡导多学科交叉的研究方法，整合分子生物学、临床医学、药物研发及数字医疗等领域的创新成果，为构建现代化医药创新体系提供坚实的学术支持。
二、征稿范围
前沿方向包括但不限于：
创新药物研发与临床评价
精准医疗与个体化治疗
细胞与基因治疗新技术
生物制剂与新型疫苗研发
转化医学与临床前研究
数字医疗与人工智能辅助诊疗
重大疾病创新治疗方案
药物递送系统与制剂技术
罕见病诊疗新进展
医疗政策与药物经济学研究

三、投稿指南
稿件要求：

原创性：未发表的研究成果，具有明确科学创新性或临床应用价值

完整性：研究设计科学，数据真实可靠，结论明确

格式规范：符合本刊投稿模板要求

投稿材料（中英文对照）：

文章标题

作者信息：姓名、单位、邮箱、ORCID

摘要：结构式摘要（目的/方法/结果/结论）

关键词：3-5个专业术语

全文：遵循IMRaD结构

伦理声明：涉及人体/动物的研究需提供伦理批准号

评审流程： 采用国际双盲同行评审，确保学术严谨性

四、目标与愿景
目标： 打造医学创新研究领域的高水平学术交流平台，推动基础研究成果向临床应用的快速转化
愿景： 成为全球医学创新的重要学术平台，促进跨学科、跨国界的学术合作与知识共享

五、数据库索引计划
国际核心数据库（申请中）：

顶级索引：SCIE, MEDLINE/PubMed, Scopus, Embase

专业数据库：International Pharmaceutical Abstracts

开放获取平台：DOAJ

学术搜索引擎：Google Scholar

中文数据库（申请中）：

国家平台：中国知网、万方数据、维普资讯

学术网络：百度学术、超星、龙源

区域平台：澳门虚拟图书馆、长江文库

媒体平台：新华网·学术中国





Journal Profile: Clinical Pharmacotherapy Research
Essential Information
Item Details
Journal Name 《临床用药研究》
English Title Clinical Pharmacotherapy Research
ISSN ISSN 3105-6741 (Print)
ISSN 3105-675X (Online)
CODEN LYYAA3
Assigning Agency Chemical Abstracts Service (CAS)
Publication Model Gold Open Access (CC BY 4.0), permanently free
Publisher Macau Sino-Foreign Medical Publishing Limited
Frequency Bimonthly
Languages Chinese, English
Submission Language Chinese (English title, abstract, keywords, author info required)
Distribution China International Book Trading Corporation (CIBTC)
Import Registration G015Z125
1. Journal Positioning
Clinical Pharmacotherapy Research is an academic journal with an international perspective, focusing on cutting-edge medical research and innovative therapeutic technologies. The journal is committed to promoting the effective integration of basic medical research and clinical practice, with particular emphasis on innovative drug development, precision medicine, biotechnology, and other frontier directions. We especially advocate interdisciplinary research approaches that integrate innovative achievements from molecular biology, clinical medicine, drug development, and digital healthcare to provide solid academic support for building a modern pharmaceutical innovation system.

2. Scope of Submission
Including but not limited to:

Innovative Drug Development and Clinical Evaluation

Precision Medicine and Personalized Treatment

New Technologies in Cell and Gene Therapy

Biologics and Novel Vaccine Development

Translational Medicine and Preclinical Research

Digital Healthcare and AI-Assisted Diagnosis and Treatment

Innovative Treatment Strategies for Major Diseases

Drug Delivery Systems and Formulation Technology

New Advances in Rare Disease Diagnosis and Treatment

Healthcare Policy and Pharmacoeconomic Research

3. Submission Guidelines
Requirements:

Originality: Unpublished work with clear scientific novelty or clinical application value

Completeness: Sound study design, reliable data, clear conclusions

Format: Adherence to journal template

Required Materials (bilingual):

Article Title

Author Information: Names, affiliations, email, ORCID

Abstract: Structured (Objective/Methods/Results/Conclusion)

Keywords: 3-5 professional terms

Full Text: IMRaD structure

Ethics Statement: Approval number for human/animal studies

Peer Review: International double-blind peer review ensures academic rigor

4. Aims and Vision
Aim: Build a high-level academic exchange platform in medical innovation research to accelerate the translation of basic research findings into clinical applications
Vision: Become a significant academic platform for global medical innovation, fostering cross-disciplinary and cross-border collaboration and knowledge sharing

5. Database Indexing Plan
International Databases (applying):

Top Indexes: SCIE, MEDLINE/PubMed, Scopus, Embase

Specialized: International Pharmaceutical Abstracts

Open Access: DOAJ

Search Engines: Google Scholar

Chinese Databases (applying):

National Platforms: CNKI, WanFang, VIP

Academic Networks: Baidu Scholar, Chaoxing, Longyuan

Regional Platforms: Macau Virtual Library, Changjiang Database

Media Platform: Xinhuanet Academic China